MyFinsight
Home
Compare
About
Recent SEC Filings
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
SpyGlass Pharma, Inc. (SGP)
SpyGlass Pharma, Inc. (SGP)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$15,759K
Free Cash flow
-$16,771K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Redemptions of short-term invest...
Stock-based compensation
Payroll-related accruals
Others
Negative Cash Flow Breakdown
Net loss
Purchases of short-term investme...
Property and equipment
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Net loss
-19,864
-13,818
-39,869
Depreciation expense
342
318
612
Loss on disposal of property and equipment
0
-
-5
Non-cash lease expense
62
63
383
Gain on lease termination
-
-
518
Stock-based compensation
2,085
1,675
2,786
Change in fair value of redeemable convertible preferred stock tranche liability
0
0
1,526
Interest receivable
-58
31
74
Other receivables
25
222
8
Prepaid expenses and other current assets
-109
805
186
Other non-current assets
-30
298
38
Accounts payable
764
953
549
Payroll-related accruals
841
-1,300
900
Accrued expenses and other current liabilities
-
-
1,672
Other current liabilities
733
-104
-
Lease liability
26
25
-441
Net cash used in operating activities
-14,839
-13,544
-32,701
Property and equipment
1,932
676
789
Purchases of short-term investments
7,000
4,000
17,001
Redemptions of short-term investments
7,999
3,009
5,996
Net cash used in investing activities
-933
-1,667
-11,794
Proceeds from exercise of stock options
31
55
170
Repurchases of common stock
0
-
1,450
Gross proceeds from issuance of redeemable convertible preferred stock
0
0
127,336
Issuance costs of redeemable convertible preferred stock
0
0
288
Gross proceeds from initial public offering of common stock, net of underwriting discounts and commissions
0
160,425
-
Payments for deferred initial public offering costs
18
2,725
1,183
Net cash provided by financing activities
13
157,755
124,585
Net increase in cash and cash equivalents
-15,759
142,544
80,090
Cash and cash equivalents, beginning of period
238,902
96,358
16,268
Cash and cash equivalents, end of period
223,143
238,902
96,358
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
SGP Cash Flow Sankey Diagram
Sankey diagram visualizing SGP cash flow for the period
Proceeds from exercise of
stock options
$31K
Net cash provided by
financing activities
$13K
Canceled cashflow
$18K
Net increase in cash
and cash...
-$15,759K
Canceled cashflow
$13K
Stock-based compensation
$2,085K
Payroll-related accruals
$841K
Accounts payable
$764K
Other current
liabilities
$733K
Depreciation expense
$342K
Prepaid expenses and
other current assets
-$109K
Non-cash lease expense
$62K
Interest receivable
-$58K
Other non-current
assets
-$30K
Lease liability
$26K
Redemptions of short-term
investments
$7,999K
Payments for deferred
initial public offering...
$18K
Net cash used in
operating activities
-$14,839K
Net cash used in
investing activities
-$933K
Canceled cashflow
$5,050K
Canceled cashflow
$7,999K
Net loss
-$19,864K
Purchases of short-term
investments
$7,000K
Other receivables
$25K
Property and equipment
$1,932K
Buy us a coffee